Proprotein Convertase Subtilisin/Kexin Type 9 Antibody and Statin-Associated Autoimmune Myopathy

Ann Intern Med. 2019 Jul 2;171(1):68-69. doi: 10.7326/L18-0705. Epub 2019 Feb 19.

Authors

Juan de Dios García-Díaz¹, Iraida M Corral-Bueno¹, José María Mesa-Latorre¹, Cristina Lozano-Durán¹, Concepción Hernández-Ahijado¹

Affiliation

¹ University Hospital Príncipe de Asturias, Madrid, Spain (J.D., I.M.C., J.M.M., C.L., C.H.).

PMID: 30776798
DOI: 10.7326/L18-0705

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal / therapeutic use*
Autoimmune Diseases / chemically induced*
Autoimmune Diseases / drug therapy*
Autoimmune Diseases / immunology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Hypercholesterolemia / drug therapy
Male
Middle Aged
Muscle Weakness / chemically induced
Muscle Weakness / drug therapy
Muscle Weakness / immunology
Muscular Diseases / chemically induced*
Muscular Diseases / drug therapy*
Muscular Diseases / immunology
Proprotein Convertase 9 / immunology*

Substances

Antibodies, Monoclonal
Hydroxymethylglutaryl-CoA Reductase Inhibitors
PCSK9 protein, human
Proprotein Convertase 9